pirinixic acid has been researched along with Metastase in 2 studies
pirinixic acid: structure
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, L | 1 |
| Wang, W | 1 |
| Dai, M | 1 |
| Li, H | 1 |
| Chen, C | 1 |
| Wang, D | 1 |
| Skrypnyk, N | 1 |
| Chen, X | 1 |
| Hu, W | 1 |
| Su, Y | 1 |
| Mont, S | 1 |
| Yang, S | 1 |
| Gangadhariah, M | 1 |
| Wei, S | 1 |
| Falck, JR | 1 |
| Jat, JL | 1 |
| Zent, R | 1 |
| Capdevila, JH | 1 |
| Pozzi, A | 1 |
2 other studies available for pirinixic acid and Metastase
| Article | Year |
|---|---|
PPARĪ± ligand, AVE8134, and cyclooxygenase inhibitor therapy synergistically suppress lung cancer growth and metastasis.
Topics: Animals; Antineoplastic Agents; Benzoates; Bezafibrate; Cell Line, Tumor; Cell Movement; Cell Prolif | 2019 |
PPARĪ± activation can help prevent and treat non-small cell lung cancer.
Topics: Animals; Arachidonic Acids; Bezafibrate; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Prol | 2014 |